Novo Nordisk raises 2024 outlook after profit beat fueled by obesity drug demand

Novo Nordisk raises 2024 outlook after profit beat fueled by obesity drug demand

Novo Nordisk Hikes Guidance as Weight-Loss Drug Sales Surge. Why the Stock’s Falling. The Danish pharmaceutical giant, which became Europe’s most valuable company last year, said Wegovy sales jumped 106% in the first quarter.Barrons.com• Google’s payments to Apple reached $20 billion in 2022, antitrust court documents show (Bloomberg) -- Alphabet Inc. paid Apple Inc. $20 billion in 2022 for Google to be the default search engine in the Safari browser, according to newly unsealed court documents in the Justice Department’s …